Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys
Open Access
- 27 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 29 (15) , 2481-2495
Abstract
Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin in muscle, and while all patients share the primary gene and biochemical defect, there is considerable patient–patient variability in clinical symptoms. We sought to develop multivariate models of serum protein biomarkers that explained observed variation, using functional outcome measures as proxies for severity. Serum samples from 39 steroid-naïve DMD boys 4 to ® aptamer profiling to define highly representative and connected proteins. Multivariate models of biomarkers were obtained for time to stand performance (strength phenotype; 17 proteins) and 6 min walk performance (endurance phenotype; 17 proteins) including some shared proteins. Identified proteins were tested with associations of mRNA expression with histological severity of muscle from dystrophinopathy patients (n = 28) and normal controls (n = 6). Strong associations predictive of both clinical and histological severity were found for ERBB4 (reductions in both blood and muscle with increasing severity), SOD1 (reductions in muscle and increases in blood with increasing severity) and CNTF (decreased levels in blood and muscle with increasing severity). We show that performance of DMD boys was effectively modeled with serum proteins, proximal strength associated with growth and remodeling pathways and muscle endurance centered on TGFβ and fibrosis pathways in muscle.Keywords
Funding Information
- European Commission Horizons 2020 (667078)
- National Institute of Child Health and Human Development (5U54HD090254)
- National Institutes of Neurologic Disorders and Stroke (R44NS095423)
- Foundation to Eradicate Duchenne
This publication has 58 references indexed in Scilit:
- The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter studyMuscle & Nerve, 2013
- Microtubules Underlie Dysfunction in Duchenne Muscular DystrophyScience Signaling, 2012
- SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyNeurology, 2011
- bioDBnet: the biological database networkBioinformatics, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Validation of Biomarker-Based Risk Prediction ModelsClinical Cancer Research, 2008
- Secreted Protein Acidic and Rich in Cysteine (SPARC) in Human Skeletal MuscleJournal of Histochemistry & Cytochemistry, 2008
- Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophyNeurology, 2005
- Regularization and Variable Selection Via the Elastic NetJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- The complete sequence of dystrophin predicts a rod-shaped cytoskeletal proteinCell, 1988